Advertisement

Alternative Treatment Approaches to Early Stage or Unresectable Hepatocellular Carcinoma Confined to the Liver

  • Francesco Izzo
  • Francesco Fiore
  • Carlo De Werra
  • Steven A. Curley
Part of the M.D. Anderson Solid Tumor Oncology Series book series (MDA)

Abstract

As noted in Chapter 2, most patients diagnosed with hepatocellular cancer (HCC) are not candidates for resection. In some patients unresectability is based on the presence of extrahepatic metastasis at the time of diagnosis. Many more patients with HCC confined to the liver are not candidates for resection because of large tumor size, multicentricity, adjacency or direct invasion to major blood vessels, or concomitant cirrhosis with inadequate functional hepatic reserve.

Keywords

Radiofrequency Ablation Transcatheter Arterial Embolization Percutaneous Ethanol Injection Microwave Ablation Metastatic Liver Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Curley SA, Izzo F, DeBellis M, Cremona F, Parisi V. Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer. Ann Surg 222:375, 1995PubMedCrossRefGoogle Scholar
  2. 2.
    Izzo F, Cremona F, Ruffolo F, et al. Outcome of 67 hepatocellular cancer patients detected during screening of 1,125 chronic hepatitis patients. Ann Surg (in press)Google Scholar
  3. 3.
    Sheu JC, Sung JL, Huang HT, et al. Intratumor injection of absolute ethanol under ultrasound guidance for the treatment of small hepatocellular carcinoma. Hepatogastroenterology 34:255, 1987PubMedGoogle Scholar
  4. 4.
    Vilana R, Bruix J, Bru C, et al. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of the small hepatocellular carcinoma. Hepatology 16:353, 1992PubMedCrossRefGoogle Scholar
  5. 5.
    Sheu JC, Huang GT, Chen DS, et al. Small hepatocellular carcinoma: intratumor ethanol treatment using new needle and guidance systems. Radiology 163:43, 1987PubMedGoogle Scholar
  6. 6.
    Livraghi T, Salmi A, Bolondi L, et al. Small hepatocellular carcinoma: percutaneous alcohol injection: results in 23 patients. Radiology 168:313, 1988PubMedGoogle Scholar
  7. 7.
    Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. Cancer 69:925, 1992PubMedCrossRefGoogle Scholar
  8. 8.
    Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long term results of hepatocellular ethanol injection. Radiology 197:101, 1995PubMedGoogle Scholar
  9. 9.
    Castells A, Bruix J, Bru C, et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 18:1121, 1993PubMedGoogle Scholar
  10. 10.
    Tanaka K, Okazaki H, Nakamura S, et al. Hepatocellular carcinoma: treatment with a combination therapy of transcatheter arterial embolization and percutaneous ethanol injection. Radiology 179:713, 1991PubMedGoogle Scholar
  11. 11.
    Livraghi T, Lazzaroni S, Pellicani S, et al. Percutaneous ethanol injection of hepatic tumors: single—session therapy with general anesthesia. AJR 161:1065, 1993PubMedGoogle Scholar
  12. 12.
    Chung SCS, Lee TW, Kwok SPY, Li AKC. Injection of alcohol to control bleeding from ruptured hepatomas. Br M J 301:421 1990CrossRefGoogle Scholar
  13. 13.
    Curley SA, Fuhrman GM, Siddik ZH, et al. Direct intratumoral injection of a novel collagen matrix gel and cisplatin effectively controls experimental live tumors. Cancer Res Ther Control 4:247, 1995Google Scholar
  14. 14.
    Curley SA, Abramson N, Benson AB, et al. Phase I study of intradose-CDDP in patients with primary and metastatic liver tumors. Hepatology 20:279A, 1994Google Scholar
  15. 15.
    Dusheiko GM, Hobbs KE, Dick R, Burroughs AK, Treatment of small hepatocellular carcinoma. Lancet 340:285, 1992PubMedCrossRefGoogle Scholar
  16. 16.
    Vetter D, Wenger JJ, Bergier JM, et al. Transcatheter oily chemoembolization in the management of advances hepatocellular carcinoma in cirrhosis: results of a Western comparative study in 60 patients. Hepatology 13:427, 1991PubMedCrossRefGoogle Scholar
  17. 17.
    Kirk S, Blumgart R, Craig B, et al. Irresectable hepatoma treated by intrahepatic iodized oil doxorubicin hydrochloride: initial results. Surgery 109:694, 1991PubMedGoogle Scholar
  18. 18.
    Hamashita Y, Takahashi M, Bussaka H, et al. Intraarterial infusion of 5-fluoro-2-deoxyuridine-C8 dissolved in a lymphographic agent in malignant liver tumors. Cancer 64:2437, 1989CrossRefGoogle Scholar
  19. 19.
    Konno T, Maeda H, Ikwai K, et al. Effect of arterial administration of high molecular weight anticancer agents SMANCS with lipid lymphographic agent on hepatoma: a preliminary report. Eur J Cancer Clin Oncol 19:1053, 1983PubMedCrossRefGoogle Scholar
  20. 20.
    Ravoet C, Bleiberg H, Gerard B. Non-surgical treatment of hepatocarcinoma. J Surg Oncol Suppl 3:104, 1993PubMedCrossRefGoogle Scholar
  21. 21.
    Konno T, Kai Y, Yamashita R, Nagamitsu A, Kimura M. Targeted chemotherapy for unresectable primary and metastatic liver cancer. Acta Oncol 33:133, 1994PubMedCrossRefGoogle Scholar
  22. 22.
    Urata K, Matsumata T, Kamakura T, Hasuo K, Sugimachi K. Lipiodolization for unresectable carcinoma: an analysis of 205 patients using univariate and multivariate analysis. J Surg Oncol 56:54, 1994PubMedCrossRefGoogle Scholar
  23. 23.
    Rossi C, Isceri S, Pagliacci M, Galaverini MC, Corinaldesi A. Chemoem-bolization of hepatocarcinoma: six years’ experience. Radiol Med (Torino) 89:835, 1995Google Scholar
  24. 24.
    Chung JW, Park JH, Han JK, Choi BI, Han MC. Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoem-bolization. AJR 165:315, 1995PubMedGoogle Scholar
  25. 25.
    Kawai S, Okamura J, Ogawa M, et al. Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma: a comparision of lipiodol transcatheter arterial embolization with and without adriamycin. Cancer Chemother Pharmacol 31(suppl 1):S1, 1992PubMedCrossRefGoogle Scholar
  26. 26.
    Venook AP, Stagg RJ, Lewis BJ, et al.Chemoembolization for hepatocellular carcinoma. J Clin Oncol 8:1108, 1990PubMedGoogle Scholar
  27. 27.
    Hirai K, Kawazoe Y, Yamashita K, et al. Arterial chemotherapy and transcatheter arterial embolization therapy for non-resectable hepatocellular carcinoma. Cancer Chemother Pharmacol 23:537, 1989CrossRefGoogle Scholar
  28. 28.
    Bismuth H, Morino M, Sherlock D, et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 163:387, 1992PubMedCrossRefGoogle Scholar
  29. 29.
    Lin DY, Liaw YF, Lee TY, Lai CH. Hepatic arterial embolization in patients with unresectable hepatoma: a randomized controlled trial. Gastroenterology 94:453, 1988PubMedGoogle Scholar
  30. 30.
    Clouse ME. Hepatic artery embolization for bleeding and tumors. Surg Clin North Am 69:419, 1989PubMedGoogle Scholar
  31. 31.
    Yamada Y, Sato M, Kawabata M, et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 55:148, 1993Google Scholar
  32. 32.
    Hwang T-L, Chen MF, Lee T-Y, et al. Resection of hepatocellular carcinoma after transcatheter arterial embolization. Arch Surg 122:756, 1987PubMedCrossRefGoogle Scholar
  33. 33.
    Berger DH, Carrasco H, Hohn DC, Curley SA. Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors: post-treatment management and complications. J Surg Oncol 60:116, 1995PubMedCrossRefGoogle Scholar
  34. 34.
    Sanchez H, vanSonnenberg E, D’agostine H, et al. Percutaneous tissue ablation by radiofrequency thermal energy as a preliminary to tumor ablation. Minim Invasive Ther 2:299, 1993CrossRefGoogle Scholar
  35. 35.
    McGahan JP, Browning PD, Brock JM, Tesluk H. Hepatic ablation using radiofrequency electocautery. Invest Radiol 25:267, 1990PubMedCrossRefGoogle Scholar
  36. 36.
    Rossi S, Fornari F, Paties C, Buscarini L. Thermal lesions induced by 480KHz localized current field in guinea pig and in pig livers. Tumori 76:54, 1990PubMedGoogle Scholar
  37. 37.
    Curley SA, Davidson BS, Fleming RYD, et al. Laparoscopically-guided bipolar radiofrequency ablation of areas of porcine liver. Surg Endosc 11:729, 1997PubMedCrossRefGoogle Scholar
  38. 38.
    Rossi S, Di Stasi M, Buscarini E, et al. Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma. Cancer J Sci Am 1:73 1995PubMedGoogle Scholar
  39. 39.
    Izzo F, Di Muria A, Ruffolo F, Parisi V, Curley SA. Intraoperative use of radiofrequency interstitial tissue ablation to treat primary and metastatic liver tumors: a pilot study. J Exp Clin Cancer Res 16:330, 1997Google Scholar
  40. 40.
    Bosman S, Phoa SS, Bosma A, Van Gemerr MJC. Effect of percutaneous interstitial thermal laser on normal liver of pigs: sonographic and histopathological correlations. Br J Surg 78:572, 1991PubMedCrossRefGoogle Scholar
  41. 41.
    Nelsoe CP, Torp-Pedersen S, Burcharth F, et al. Interstitial hyperthermia of colorectal liver metastases with an US-guided Nd-Yag laser with a diffuser tip: a pilot clinical study. Radiology 187:333, 1993Google Scholar
  42. 42.
    Sato M, Watanabe Y, Ueda S, et al. Microwave coagulation therapy for hepatocellular carcinoma. Gastroenterology 110:1507, 1996PubMedCrossRefGoogle Scholar
  43. 43.
    Curley SA, Stone DL, Newman RA, et al. A novel system to treat human hepatocellular cancer: a phase I study. Ann Surg Oncol 1:389, 1994PubMedCrossRefGoogle Scholar
  44. 44.
    Fuhrman GM, Cromeens DM, Newman RA, et al. Hepatic arterial infusion of verapamil and doxorubicin with complete hepatic venous isolation and extracorporeal chemofiltration: pharmacologic evaluation of reduction in systemic drug exposure and assessment of hepatic toxicity. Surg Oncol 3:17, 1994PubMedCrossRefGoogle Scholar
  45. 45.
    Palmieri G, Cimmino L, Gravina A, et al. Thymostimulin treatment of hepatocellular carcinoma: preliminary data. In: Proceedings of the First International Conference on Hepatobiliary Tumors, Vol. 1, 1992, p. 52Google Scholar
  46. 46.
    Balch G, Izzo F, Chiao P, Klostergaard J, Curley SA. Thymostimulin (TP-1) activates Kupffer cells to produce cytotoxicity against human hepatocellular cells. Ann Surg Oncol 4:149, 1997PubMedCrossRefGoogle Scholar
  47. 47.
    Siegall CB, Kreitman RJ, Fitzgerald DJ, Pastan I. Antitumor effects of interleukin 6-Pseudomonas exotoxin chimeric molecules against the human hepatocellular carcinoma. PLC/PRF/5 in mice. Cancer Res 51:2831, 1991PubMedGoogle Scholar
  48. 48.
    Wu GY, Wu CH Stockert RJ. Model for specific rescue of normal hepatocytes during methotrexate treatment of hepatic malignancy. Pro Natl Acad Sci USA 80:3078, 1983CrossRefGoogle Scholar
  49. 49.
    Wu GY, Keegan-Rogers V, Franklin S, et al. Targeted antagonism of galac-tosamine toxicity in normal rate hepatocytes in vitro. J Biol Chem 263:4719, 1988PubMedGoogle Scholar
  50. 50.
    Keegan-Rogers V, Wu GY. Targeted protection of hepatocytes from galac-tosamine toxicity in vivo. Cancer Chemother Pharmacol 26:93, 1990PubMedCrossRefGoogle Scholar
  51. 51.
    Wilson JM, Grossman M, Wu CH, et al. Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low density lipoportein receptor-deficient rabbits. J Biol Chem 267:963, 1992PubMedGoogle Scholar
  52. 52.
    Ferry N, Duplessis O, Houssin D, et al. Retroviral-mediated gene transfer into hepatocytes in vivo. Proc Natl Acad Sci USA 88:8377 1991PubMedCrossRefGoogle Scholar
  53. 53.
    Zhu N, Liggitt D, Liu Y, Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science 261:209, 1993PubMedCrossRefGoogle Scholar
  54. 54.
    Masuda K, Takahashi K, Hirano K, Takagishi Y. Selective antitumor effect of thioether-linked immunotoxins composed of gelonin and monoclonal antibody to alpha-fetoprotein or its (ab’)2 fragment. Tumoru Biol 15:175, 1994CrossRefGoogle Scholar
  55. 55.
    Plautz GE, Yang ZY, Wu BY, et al. Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc Natl Acad Sci USA 90:4645, 1993PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Francesco Izzo
  • Francesco Fiore
  • Carlo De Werra
  • Steven A. Curley

There are no affiliations available

Personalised recommendations